Enzymatica AB
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
ENZY | ST
Overview
Corporate Details
- ISIN(s):
- SE0003943620 (+4 more)
- LEI:
- 529900HNJP0335URJQ76
- Country:
- Sweden
- Address:
- Ideon Science Park, 223 70 Lund
- Website:
- https://www.enzymatica.se/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Enzymatica AB is a life science company that develops and sells medical devices designed to address infection-related diseases. The company's core business is centered on a patented barrier technology that utilizes marine enzymes to support the body's natural defenses against viruses and microorganisms. Its primary product, ColdZyme®, is a mouth spray that creates a protective barrier in the pharynx, clinically proven to reduce the duration of the common cold and alleviate its symptoms by addressing the underlying cause of infection. Enzymatica focuses on scientifically-backed solutions for the treatment and prevention of diseases and symptoms in the upper respiratory tract.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Enzymatica AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Enzymatica AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Enzymatica AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-12 | Helene Willberg | Other | Buy | 48,000 | 147,840.00 SEK |
